Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Solesence (SLSN) over the last 13 years, with Q2 2025 value amounting to $225000.0.

  • Solesence's Gains from Investment Securities changed N/A to $225000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $325000.0, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2024, which is 891.18% down from last year.
  • Latest data reveals that Solesence reported Gains from Investment Securities of $225000.0 as of Q2 2025.
  • In the past 5 years, Solesence's Gains from Investment Securities registered a high of $3.2 million during Q1 2023, and its lowest value of $11000.0 during Q4 2022.
  • Over the past 4 years, Solesence's median Gains from Investment Securities value was $42000.0 (recorded in 2021), while the average stood at $331105.8.
  • As far as peak fluctuations go, Solesence's Gains from Investment Securities tumbled by 9355.14% in 2021, and later skyrocketed by 838886.84% in 2023.
  • Solesence's Gains from Investment Securities (Quarter) stood at $38000.0 in 2021, then tumbled by 71.05% to $11000.0 in 2022, then soared by 1227.27% to $146000.0 in 2023, then soared by 54.11% to $225000.0 in 2025.
  • Its last three reported values are $225000.0 in Q2 2025, $100000.0 for Q1 2025, and $146000.0 during Q4 2023.